Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Combining interscalene block with infraclavicular block for humerus surgery provides a unique surgical anaesthesia and postoperative analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interscalene block provides effective surgical anaesthesia for shoulder and proximal arm surgery. However, sometimes it can be inadequate for distal arm surgery. Combining infraclavicular block with interscalene block may provide a successful surgical anaesthesia for humerus surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Humerus Fracture

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

interscalene infraclavicular humerus surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients accepting peripheral nerve block technique for humerus surgery
* Unilateral orthopedic humerus surgery
* 18 years of age or older

Exclusion Criteria

* Patients refused peripheral nerve block
* Non-cooperate patients
* Neuropathy of any etiology in the affected extremity

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bora Bilal

Assist prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bora Bilal, Asist. Prof.

Role: CONTACT

Phone: +903442803245

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

76263

Identifier Type: -

Identifier Source: org_study_id